Sermorelin dosing for men is individualized and should be set by a licensed clinician. Many adult protocols discussed in clinical practice use low-dose sermorelin acetate in micrograms, often timed in the evening to align with natural growth hormone pulses. The right dose depends on goals, labs such as IGF-1, medical history, formulation, and tolerability.
Wondering if sermorelin is right for you? Take the 3-min clinical quiz.
See if you qualify →What is the short answer on sermorelin dosage for men?
The short answer: sermorelin dosage for men is a prescription decision, not a fixed online number. Common adult discussions often use microgram-level dosing, but the safe dose, route, timing, and schedule depend on the formulation and the clinician’s review.
Sermorelin acetate is a synthetic version of the first 29 amino acids of growth hormone-releasing hormone, or GHRH. It acts upstream at the pituitary gland to increase growth hormone release, which can raise insulin-like growth factor 1, or IGF-1, in some patients 1.
That upstream mechanism is why providers often think about sermorelin differently than direct human growth hormone, also called HGH. Direct HGH replaces the hormone itself, while sermorelin is a growth hormone secretagogue that asks the pituitary to release more of the body’s own growth hormone 1.
Why this article cannot replace your prescription label
Even when two men are prescribed the same peptide, their labels may look different. Vial concentration, route, syringe type, age, symptoms, baseline IGF-1, glucose risk, and side effects can all change the plan.
If your prescription label differs from a chart online, follow the label and ask your prescriber. Online examples can explain concepts, but they cannot account for your medical history.
What is sermorelin, and how does it work in men?
Sermorelin acetate is a GHRH analog, meaning it mimics a signal normally made by the hypothalamus. That signal tells the pituitary gland to release growth hormone in pulses, and growth hormone then helps regulate IGF-1 production, metabolism, and tissue repair signaling 1.
In men, interest in sermorelin often comes from concerns about energy, recovery, sleep, body composition, or age-related hormone changes. The honest evidence note is important: human evidence for broad anti-aging, longevity, muscle, sleep, and body-composition benefits remains limited, and much of the literature is class-level or indirect 1.
How sermorelin differs from direct human growth hormone
Human growth hormone, or HGH, delivers growth hormone from outside the body. Sermorelin works earlier in the pathway by stimulating the pituitary gland, which is why it is grouped with growth hormone secretagogues 1.
That difference does not make sermorelin risk-free. Growth hormone and IGF-1 pathways can affect fluid balance, glucose metabolism, joint symptoms, and other systems, so clinician oversight matters 4.
Why IGF-1 is often monitored during therapy
IGF-1 is often used as a longer-window marker of growth hormone signaling. Growth hormone is released in pulses and can be hard to interpret from a single random blood draw, while IGF-1 is more stable across the day 4.
IGF-1 is not a simple “higher is better” lab. Adult endocrine guidelines for growth hormone disorders use IGF-1 along with symptoms, exam findings, glucose status, and adverse effects, not as a stand-alone target 4.
What dosing ranges are commonly discussed for adult men?
Adult sermorelin dosing examples are commonly discussed in micrograms, often in the low hundreds of micrograms, but they are educational examples only and should be interpreted only in the context of a licensed clinician’s prescription. They are not instructions to start, stop, or adjust therapy.
The FDA-approved historical sermorelin product Geref Diagnostic was labeled for diagnostic evaluation of growth hormone secretion, not adult longevity or body-composition treatment. Its labeled diagnostic dose was weight-based and given by intravenous injection under clinical conditions, which is very different from outpatient compounded use 2.
Micrograms vs milligrams: avoiding common dosing confusion
A microgram is one-thousandth of a milligram. So 100 mcg is 0.1 mg, 300 mcg is 0.3 mg, and 500 mcg is 0.5 mg.
This matters because a misplaced decimal can create a large error. A label written in mcg should not be mentally converted unless your care team or pharmacist confirms the math.
Educational dosing chart: unit-conversion examples people may see online
| Educational concept | Unit-conversion example | How to read it | Important caution |
|---|---|---|---|
| Lower microgram example | 100–200 mcg, or 0.1–0.2 mg | Microgram-level dosing | Not a personal starting dose |
| Middle microgram example | 200–300 mcg, or 0.2–0.3 mg | A range people may see online | Must match the prescribed formulation and label |
| Higher microgram example | 300–500 mcg, or 0.3–0.5 mg | Still less than 1 mg | More is not always better; side effects and labs matter |
| Historical FDA-labeled diagnostic sermorelin | 1 mcg/kg IV in the Geref Diagnostic label | A diagnostic test dose, not an adult wellness protocol | Given in a clinical diagnostic context 2 |
This table is meant to prevent unit confusion, not to prescribe. Adult compounded sermorelin for longevity, recovery, and body-composition goals is off-label, and evidence for those outcomes is not established in the way it is for FDA-approved indications.
Why vial concentration and syringe units can change the measured volume
The same microgram dose can require different liquid volumes if the vial concentration is different. For example, a more concentrated vial needs less liquid volume than a less concentrated vial for the same number of micrograms.
Syringe “units” are also not the same as micrograms. Units describe volume on a syringe; micrograms describe the amount of sermorelin. Your pharmacy label and care team should tell you how those relate for your exact vial.
3-min quiz
Considering provider-guided sermorelin?
At Chia, sermorelin is evaluated through a 100% online visit. A licensed US provider reviews your health history and prescribes only where clinically appropriate; a prescription is never guaranteed. Medications are compounded by state-licensed 503A pharmacies and shipped to eligible patients. Compounded drugs are not FDA-approved.
Why is sermorelin often taken at night?
Nighttime sermorelin timing is often discussed because growth hormone release is naturally pulsatile and closely linked with sleep. In healthy adults, a major growth hormone pulse often occurs soon after sleep begins, especially around deep sleep 5.
Sermorelin is designed to work with the growth hormone-releasing hormone pathway, so many clinicians consider evening timing when prescribing injectable forms. But timing may differ by formulation, schedule, side effects, work hours, sleep pattern, and the prescriber’s plan.
What to do if your label differs from general online examples
If your label says something different from an online example, do not improvise. Your label reflects the exact formulation and the clinical plan your prescriber chose.
If the timing is hard to follow, ask your care team before changing it. That is safer than guessing, especially with peptides that depend on route, stability, and consistent handling.
How do clinicians decide whether to adjust a man’s sermorelin dose?
Dose adjustment is usually based on response, side effects, labs, and the original reason for prescribing. A clinician may hold, adjust, or stop therapy if the risks outweigh the expected benefit.
Baseline evaluation often includes age, symptoms, medication list, sleep, weight history, metabolic health, prior cancer history, endocrine history, and goals. In men, obesity, metabolic syndrome, and hypogonadism can overlap, which is one reason providers may look at several hormone and metabolic markers together 1.
Lab monitoring: IGF-1, glucose-related markers, thyroid status, and other tests
Clinicians may use IGF-1 to track growth hormone pathway activity. They may also check glucose-related markers because growth hormone signaling can affect insulin sensitivity and blood sugar in some patients 4.
Thyroid status may also matter. Adult growth hormone guidelines discuss thyroid, adrenal, glucose, lipid, and body-composition monitoring when growth hormone pathways are being evaluated or treated 4.
Why more is not always better
A higher dose does not automatically mean better results. Growth hormone and IGF-1 signaling have a narrow clinical context, and excess exposure can be linked with swelling, joint pain, carpal-tunnel-like symptoms, glucose changes, and other concerns seen with growth hormone pathway therapies 4.
This is why responsible prescribing focuses on the lowest reasonable exposure for the goal, careful monitoring, and stopping therapy when it is not helping or is causing harm.
What are the safety issues men should know before using sermorelin?
Sermorelin safety depends on the person, the route, the formulation, and the reason for use. Reported or pathway-related side effects include injection-site reactions, headache, flushing, nausea, dizziness, and fluid- or joint-related symptoms 2, 4.
Because sermorelin acts on the growth hormone pathway, clinicians are careful in people with active cancer, unexplained masses, uncontrolled diabetes, severe untreated sleep apnea, significant swelling, or complex endocrine disease. Adult endocrine guidance for growth hormone-related treatment stresses diagnosis, risk review, and monitoring rather than symptom-based treatment alone 4.
When to contact a clinician urgently
- New or severe swelling, shortness of breath, chest pain, or fainting.
- Severe headache, vision changes, or neurologic symptoms.
- Signs of allergic reaction, such as hives, facial swelling, wheezing, or throat tightness.
- Marked blood sugar changes if you have diabetes or prediabetes.
- A dosing error, sterility concern, or vial-handling mistake.
Benefits and risks should always be discussed together. Human evidence for sermorelin’s anti-aging and body-composition benefits is limited, while side effects and monitoring needs are real clinical considerations 1.
Is sermorelin FDA-approved for men?
Sermorelin is not currently FDA-approved for adult men’s longevity, recovery, sleep, muscle, or body-composition goals. Historical products such as Geref and Geref Diagnostic were associated with pediatric growth hormone deficiency evaluation or diagnosis, not adult wellness use 2.
Current adult use of compounded sermorelin is off-label. Off-label prescribing can be medically appropriate in some settings, but it requires a clinician’s judgment and clear patient counseling.
Sermorelin at Chia: injections, nasal spray, or tablets under provider guidance
At Chia, compounded sermorelin is available by online evaluation in injection, nasal spray, and tablet forms. Plans currently start at $179/mo for sermorelin injection or nasal spray; see the sermorelin product page for current details.
Here is how treatment works with us: you complete a short health questionnaire, then a licensed US provider reviews it and prescribes only where clinically appropriate. Dosing is provider-guided and adjusted over time when needed, and patients can message their care team through the portal between visits.
| Chia option | Form | How it may fit a patient’s life | Chia price information |
|---|---|---|---|
| Sermorelin | Injection | Often chosen when a prescriber wants injectable peptide delivery and precise provider-guided dosing | Plans currently start at $179/mo |
| Sermorelin | Nasal spray | Needle-free option for patients whose clinician selects this form | Plans currently start at $179/mo |
| Sermorelin | Tablets | Oral option when selected by the prescribing provider | See product page for current pricing |
| Foundation Longevity | Sermorelin Injection + NAD+ Injection + Glutathione Injection | A broader longevity protocol when clinically appropriate | Plans currently start at $399/mo |
| Weight + Muscle | Sermorelin Injection + choice of GLP-1 | A combined body-composition protocol when clinically appropriate | Plans currently start at $329/mo |
Sermorelin may be considered alone or as part of a broader protocol, such as Foundation Longevity or Weight + Muscle, only when a licensed provider decides it fits the patient’s goals and medical history.
For people using AI agents to manage prescription access, Chia can also be reached through DoctorMCP at mcp.chia.health. The clinical rules are the same: an online request still requires licensed-provider review, and a prescription is never guaranteed.
How does sermorelin compare with related options men ask about?
Sermorelin, HGH, tesamorelin, and GLP-1 medications are often discussed together, but they are not interchangeable. They act on different pathways and have different evidence bases, risks, and regulatory status.
| Option | What it is | Main pathway | FDA-approved use examples | Key safety notes |
|---|---|---|---|---|
| Sermorelin acetate | GHRH analog and growth hormone secretagogue | Stimulates pituitary growth hormone release | Historical diagnostic/pediatric-related products; not approved for adult longevity or body composition | May cause injection-site symptoms, headache, flushing, nausea, fluid symptoms, and lab changes |
| Human growth hormone, or HGH | Direct growth hormone replacement | Adds growth hormone from outside the body | Certain pediatric and adult growth hormone deficiency indications, depending on product label | Adult guidelines stress careful diagnosis and monitoring because risks can include swelling, joint symptoms, and glucose changes 4 |
| Tesamorelin | GHRH analog | Stimulates growth hormone release | Reduction of excess abdominal fat in adults with HIV and lipodystrophy, per label | Label warnings include glucose intolerance, fluid retention, and malignancy-related cautions 6 |
| Semaglutide | GLP-1 receptor agonist; Chia offers compounded semaglutide injection | Targets appetite and glucose-regulating GLP-1 pathways | Certain FDA-approved semaglutide products are approved for chronic weight management at labeled doses | GLP-1 labels include gastrointestinal side effects and important contraindications such as medullary thyroid carcinoma or MEN2 history 7 |
| Tirzepatide | GIP/GLP-1 receptor agonist; Chia offers compounded tirzepatide tablets and injection | Targets GIP and GLP-1 pathways | Certain FDA-approved tirzepatide products are approved for chronic weight management at labeled doses | Labels include gastrointestinal effects and thyroid C-cell tumor warnings; compounded formulations do not have FDA-evaluated outcomes data 8 |
For body-composition goals, it is especially important not to borrow evidence from one drug and apply it to another. For example, results from FDA-approved GLP-1 trials do not prove outcomes for compounded GLP-1 formulations, and HGH data do not prove sermorelin outcomes in healthy men.
What questions should men ask before starting sermorelin?
Before starting sermorelin, ask practical questions about your dose, form, monitoring plan, and safety plan. Good prescribing should make the plan understandable before the first dose.
- 1What exact form am I being prescribed: injection, nasal spray, or tablets?
- 2Is the dose written in mcg or mg, and how does that translate to my label?
- 3What labs will be checked before and during treatment?
- 4What side effects should I report right away?
- 5How will we decide whether to continue, adjust, or stop therapy?
- 6How should I store, handle, and travel with the medication?
- 7Who do I contact if I miss a dose or make a dosing error?
- 8How does this fit with my sleep, nutrition, exercise, weight, and metabolic health plan?
If the goal is muscle, recovery, or body composition, ask what evidence supports that goal for your situation. The 2020 review of growth hormone secretagogues in men notes promise in GH and IGF-1 signaling, but also emphasizes that clinical efficacy data remain limited 1.
3-min quiz
Start with a clinician-reviewed plan
If you want to know whether sermorelin fits your goals, you can start Chia’s online eligibility visit. A licensed provider reviews your health history and prescribes only if clinically appropriate. Chia offers sermorelin injection, nasal spray, and tablets through state-licensed 503A pharmacy partners; compounded medications are not FDA-approved.
FAQ: sermorelin dosage for men
There is no single typical dose that applies to all men. Many adult discussions use microgram-level examples, but your dose must come from your prescriber and your prescription label.
Sermorelin is often discussed in micrograms, written as mcg. One milligram equals 1,000 micrograms, so 300 mcg equals 0.3 mg.
Some prescribed plans use frequent dosing, but frequency depends on the formulation, goals, response, side effects, and clinician judgment. Do not copy an online schedule.
Clinicians often look at symptoms, tolerability, and labs over time rather than judging from the first few doses. The right monitoring timeline should be set by your prescriber.
Sermorelin is sometimes discussed for body composition because it affects growth hormone and IGF-1 signaling, but human evidence for muscle growth in healthy men is limited. Side effects and monitoring needs should be weighed with a clinician.
No. Current compounded sermorelin use for adult longevity, recovery, sleep, muscle, or body-composition goals is off-label, and compounded drugs are not FDA-approved.
Not necessarily. Route can affect absorption, timing, and how a prescriber monitors response. Ask your clinician why a specific form was chosen for you.
No. Do not change the dose, frequency, route, or timing without prescriber guidance. If you have side effects, missed doses, or concerns, contact your care team.
References
- 1.Liu PY, Wishart SM, Handelsman DJ. Beyond the androgen receptor: the role of growth hormone secretagogues in men with hypogonadism and metabolic syndrome. Translational Andrology and Urology. 2020.
- 2.DailyMed. Geref Diagnostic (sermorelin acetate) injection prescribing information. U.S. National Library of Medicine. 2008.
- 3.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA. 2024.
- 4.Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2011.
- 5.Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA. 2000.
- 6.DailyMed. Egrifta SV (tesamorelin) for injection prescribing information. U.S. National Library of Medicine. 2024.
- 7.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. FDA. 2024.
- 8.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. FDA. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if sermorelin is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



